216 related articles for article (PubMed ID: 22584708)
1. The Hirschsprung's-multiple endocrine neoplasia connection.
Moore SW; Zaahl M
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):63-7. PubMed ID: 22584708
[TBL] [Abstract][Full Text] [Related]
2. Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET.
Moore SW; Zaahl MG
Pediatr Surg Int; 2008 May; 24(5):521-30. PubMed ID: 18365214
[TBL] [Abstract][Full Text] [Related]
3. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.
Ito S; Iwashita T; Asai N; Murakami H; Iwata Y; Sobue G; Takahashi M
Cancer Res; 1997 Jul; 57(14):2870-2. PubMed ID: 9230192
[TBL] [Abstract][Full Text] [Related]
4. An extended family with familial medullary thyroid carcinoma and Hirschsprung's disease.
Igarashi T; Okamura R; Jikuzono T; Uchino S; Sugitani I; Shimizu K
J Nippon Med Sch; 2014; 81(2):64-9. PubMed ID: 24805091
[TBL] [Abstract][Full Text] [Related]
5. [Hirschsprung's disease, RET proto-oncogene mutation and prophylactic thyroidectomy].
Marcacuzco Quinto AA; Martínez Pueyo JI; Gómez Rodríguez P; de la Cruz Vigo F
Med Clin (Barc); 2014 Aug; 143(4):185-6. PubMed ID: 24342010
[No Abstract] [Full Text] [Related]
6. Genotype-phenotype correlation in multiple endocrine neoplasia type 2.
Raue F; Frank-Raue K
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):69-75. PubMed ID: 22584709
[TBL] [Abstract][Full Text] [Related]
7. Occurrence of MEN 2a in familial Hirschsprung's disease: a new indication for genetic testing of the RET proto-oncogene.
Decker RA; Peacock ML
J Pediatr Surg; 1998 Feb; 33(2):207-14. PubMed ID: 9498388
[TBL] [Abstract][Full Text] [Related]
8. [Thyroid carcinomas and Hirschsprung's disease--10-year experience with molecular genetic testing of the RET proto-oncogene].
Bendlová B; Dvoráková S; Václavíková E; Sýkorová V; Vlcek P; Skába R
Vnitr Lek; 2006 Oct; 52(10):926-34. PubMed ID: 17063805
[TBL] [Abstract][Full Text] [Related]
9. RET haplotype, not linked to the C620R activating mutation, associated with Hirschsprung disease in a novel MEN2 family.
Quedas EP; Longuini VC; Sekiya T; Coutinho FL; Toledo SP; Tannuri U; Toledo RA
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):57-61. PubMed ID: 22584707
[TBL] [Abstract][Full Text] [Related]
10. Familial associations in medullary thyroid carcinoma with Hirschsprung disease: the role of the RET-C620 "Janus" genetic variation.
Moore SW; Zaahl M
J Pediatr Surg; 2010 Feb; 45(2):393-6. PubMed ID: 20152359
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2.
Wagner SM; Zhu S; Nicolescu AC; Mulligan LM
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):77-84. PubMed ID: 22584710
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic thyroidectomy in pediatric carriers of multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma: mutation in C620 is associated with Hirschsprung's disease.
Bütter A; Gagné J; Al-Jazaeri A; Emran MA; Deal C; St-Vil D
J Pediatr Surg; 2007 Jan; 42(1):203-6. PubMed ID: 17208566
[TBL] [Abstract][Full Text] [Related]
13. C618R mutation in exon 10 of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease.
Caron P; Attié T; David D; Amiel J; Brousset F; Roger P; Munnich A; Lyonnet S
J Clin Endocrinol Metab; 1996 Jul; 81(7):2731-3. PubMed ID: 8675603
[TBL] [Abstract][Full Text] [Related]
14. Surgical approach to medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2.
Tavares MR; Toledo SP; Montenegro FL; Moyses RA; Toledo RA; Sekyia T; Cernea CR; Brandão LG
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):149-54. PubMed ID: 22584721
[TBL] [Abstract][Full Text] [Related]
15. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the RET proto-oncogene in a kindred with multiple endocrine neoplasia type 2A and Hirschsprung's disease.
Inoue K; Shimotake T; Inoue K; Tokiwa K; Iwai N
J Pediatr Surg; 1999 Oct; 34(10):1552-4. PubMed ID: 10549772
[TBL] [Abstract][Full Text] [Related]
17. Oncological implications of RET gene mutations in Hirschsprung's disease.
Sijmons RH; Hofstra RM; Wijburg FA; Links TP; Zwierstra RP; Vermey A; Aronson DC; Tan-Sindhunata G; Brouwers-Smalbraak GJ; Maas SM; Buys CH
Gut; 1998 Oct; 43(4):542-7. PubMed ID: 9824583
[TBL] [Abstract][Full Text] [Related]
18. A novel Czech kindred with familial medullary thyroid carcinoma and Hirschsprung's disease.
Dvoráková S; Dvoráková K; Malíková M; Skába R; Vlcek P; Bendlová B
J Pediatr Surg; 2005 Jun; 40(6):e1-6. PubMed ID: 15991157
[TBL] [Abstract][Full Text] [Related]
19. Total thyroidectomy for hereditary medullary thyroid carcinoma 12 years after correction of Hirschsprung's disease.
Sasaki Y; Shimotake T; Go S; Iwai N
Eur J Surg; 2001 Jun; 167(6):467-9. PubMed ID: 11471675
[No Abstract] [Full Text] [Related]
20. Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease.
Arighi E; Popsueva A; Degl'Innocenti D; Borrello MG; Carniti C; Perälä NM; Pierotti MA; Sariola H
Mol Endocrinol; 2004 Apr; 18(4):1004-17. PubMed ID: 14715928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
